Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

4.77
BATS BZX Real-Time Price
As of 2:05pm ET
 +0.03 / +0.63%
Today’s Change
4.60
Today|||52-Week Range
10.89
-39.62%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Revenue and IncomeNet Revenues16.4M21.4M21.3M33.7M
 
 
 
 
 
Cost of Goods Sold--46.0K711.0K1.9M
 
 
 
 
Depreciation And Amortization2.2M--1.5M1.5M
 
 
 
 
 
Operating ExpensesGross Income--21.4M19.0M30.3M
 
 
 
 
General Expenses52.5M64.1M49.1M60.2M
 
 
 
 
 
Research And Development37.8M44.7M32.9M41.0M
 
 
 
 
 
Total Operating Expenses54.7M64.1M51.4M63.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-38.3M-42.7M-30.1M-29.9M
 
 
 
 
 
Extraordinary Charge0.000.000.00-14.6M
 
 
Interest Expense On Debt4.5M5.7M8.6M6.6M
 
 
 
 
 
Other Expenses356.0K337.0K-43.0K-64.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-42.4M-48.1M-38.7M-51.0M
 
 
 
 
 
Minority Interest-208.0K-242.0K-185.0K-208.0K
 
 
 
 
 
Net Income-42.6M-47.8M-38.5M-50.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS112.4M115.6M116.1M126.2M
 
 
 
 
 
Shares To Calculate EPS Diluted112.4M115.6M116.1M126.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.38-$0.41-$0.33-$0.40
 
 
 
 
 
EPS Diluted-$0.38-$0.41-$0.33-$0.40